These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5328184)

  • 1. [On the subject of the protective action of cysteamine and cystamine in rats having received lethal doses of Myleran].
    Dunjic A
    Pathol Biol; 1966 May; 14(9):554-8. PubMed ID: 5328184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of sulfur-containing radiation-protective drugs on biochemical changes in irradiation of the organism].
    Dzharak'ian TK; Golubentsev DA; Vladimirov VG
    Radiobiologiia; 1965; 5(3):415-22. PubMed ID: 5873969
    [No Abstract]   [Full Text] [Related]  

  • 3. [Somatic and genetic lesions after fractionated x-irradiation and an attempt at chemical radiation protection].
    Baev IA; Baĭrakova AK; Benova DK
    Radiobiologiia; 1974; 14(5):677-80. PubMed ID: 4431911
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic cysteamine and non-protein sulfhydryl levels following cystamine or cysteamine treatment of galactosamine-poisoned rats.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Drug Chem Toxicol; 1985; 8(6):483-94. PubMed ID: 4092620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the enhancement of the radiation-protecting action of anabolic steroids].
    Panek R
    Strahlentherapie; 1972 May; 143(5):559-69. PubMed ID: 5055954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of endogenous histamine in the protective effect of radiation-protective agents].
    Goncharenko EN; Kudriashov IuB; Briedis I
    Dokl Akad Nauk SSSR; 1970; 191(4):948-50. PubMed ID: 5469674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemical state and content of radioprotector in some rat tissues at early time-intervals after cystamine administration].
    Koshcheenko NN; Filippovich IV; Romantsev EF
    Vopr Med Khim; 1970; 16(1):69-72. PubMed ID: 5435390
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
    Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
    Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the radiation protective effects of cystamine and cysteamine on the skin].
    Van Caneghem P
    Strahlentherapie; 1969 Feb; 137(2):231-7. PubMed ID: 5822230
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of aniline methemoglobinemia by sulfur-containing amines and methylene blue].
    Predtechenskiĭ MB; Zaugol'nikov SD
    Farmakol Toksikol; 1967; 30(6):749-50. PubMed ID: 5598452
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protective action of cystamine in repeated irradiation].
    Vladimirov VG; Smirnov AD
    Radiobiologiia; 1981; 21(1):127-30. PubMed ID: 7220819
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation damage and its repair after local X-ray irradiation of the head of the rats protected with cystamine.
    Volenec K; Vodicka I; Kuna P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(4):519-33. PubMed ID: 6599825
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug shows potential for treatment of Huntington's disease.
    Frankish H
    Lancet Neurol; 2006 Jun; 5(6):476-7. PubMed ID: 16739299
    [No Abstract]   [Full Text] [Related]  

  • 14. CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease.
    Dubinsky R; Gray C
    Mov Disord; 2006 Apr; 21(4):530-3. PubMed ID: 16258942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective action of radioprotectors and shielding against high-energy protons in experiments with rats].
    Shashkov VS; Karsanova SK; Iasnetsov VV
    Aviakosm Ekolog Med; 2008; 42(2):58-61. PubMed ID: 18714729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and clinical research on the radio-protective action of cysteamine and cystamine. III. Clinical research.
    BALDINI G; FERRI L
    Br J Radiol; 1957 May; 30(353):271-3. PubMed ID: 13426508
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental and clinical research on the radio-protective action of cysteamine and cystamine. II. Experimental research upon mammals.
    BALDINI G; FERRI L
    Br J Radiol; 1957 Feb; 30(350):95-8. PubMed ID: 13396220
    [No Abstract]   [Full Text] [Related]  

  • 18. Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide.
    Butler JD; Zatz M
    J Clin Invest; 1984 Aug; 74(2):411-6. PubMed ID: 6746900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance for radioprotective effect in mammals of pharmacological and biochemical actions of cysteamine and related substances.
    Bacq ZM; Beaumariage ML; Van Caneghem P
    Ann Ist Super Sanita; 1965; 1(9):639-45. PubMed ID: 5889643
    [No Abstract]   [Full Text] [Related]  

  • 20. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
    Tsai SJ
    Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.